Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
IO Biotech, Inc. (IOBT) had Debt to Equity Ratio of 18.29 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.38M |
|
-- |
|
-- |
|
$19.36M |
|
$-19.36M |
|
$9.31M |
|
$-10.04M |
|
$-10.04M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-19.36M |
|
$-19.29M |
|
66.94M |
|
66.94M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$36.83M |
|
$0.54M |
|
$3.12M |
|
$39.96M |
|
$18.31M |
|
$16.66M |
|
$20.73M |
|
$39.05M |
|
$0.91M |
|
$0.91M |
|
$0.91M |
|
69.69M |
|
| Cash Flow Statement Financials | |
$-61.37M |
|
$-0.06M |
|
$32.76M |
|
$60.30M |
|
$30.93M |
|
$-29.37M |
|
$4.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.01 |
|
-- |
|
-- |
|
0.95 |
|
|
Debt to Equity Ratio |
18.29 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-919.66% |
|
-919.65% |
|
-20.97% |
|
-47.67% |
|
$0.01 |
|
$-0.92 |
|
$-0.92 |
|